Genome-wide association study identifies five risk loci for pernicious anemia

Area of Science:

• Genetics
• Immunology
• Gastroenterology

Background:

• Pernicious anemia is a rare autoimmune disorder causing vitamin B12 deficiency due to intrinsic factor loss, often linked to autoimmune gastritis.
• Individuals with pernicious anemia exhibit a higher prevalence of other autoimmune conditions, including type 1 diabetes, vitiligo, and autoimmune thyroid diseases.
• While its autoimmune basis is recognized, the genetic factors contributing to pernicious anemia susceptibility remain largely unexplored.

Purpose of the Study:

• To investigate the genetic underpinnings of pernicious anemia.
• To identify specific genetic variants associated with an increased risk of developing pernicious anemia through a large-scale genome-wide association study.

Main Methods:

• A genome-wide association study (GWAS) meta-analysis was performed.
• The study included 2166 cases of pernicious anemia and 659,516 European controls sourced from population-based biobanks.
• Statistical analyses identified genome-wide significant signals in relevant genes.

Main Results:

• Genome-wide significant associations were discovered for several genes.
• Key genes identified include PTPN22 (rs6679677), PNPT1 (rs12616502), HLA-DQB1 (rs28414666), IL2RA (rs2476491), and AIRE (rs74203920).
• These findings provide robust evidence linking specific genetic variants to pernicious anemia risk.

Conclusions:

• The study successfully identified significant genetic risk factors for pernicious anemia.
• The identified genes, including PTPN22, HLA-DQB1, and AIRE, are implicated in immune regulation and autoimmune processes.
• These results enhance our understanding of the genetic susceptibility to pernicious anemia and its autoimmune etiology.